CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 253 enrolled
Drug / intervention
Stannous Fluoride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02750943
NCT02750943N/ACompleted
CompareCT.gov

A Clinical Study Investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice

GlaxoSmithKline·interventional·Posted Apr 26, 2016·Updated Oct 26, 2017

In Brief

A clinical study evaluating Stannous Fluoride and Sodium Monofluorophosphate for Gingivitis. Completed, enrolled 253 participants across 1 site.

Detailed Summary

This will be a single-center, 12 week, examiner-blind, randomized, stratified (gender and baseline mean whole mouth MGI score), two-treatment, parallel group, clinical study in healthy adult volunteers with moderate gingivitis. This study will evaluate the efficacy of a dentifrice containing 0.454% weight by weight (w/w) stannous fluoride to control gingivitis and gingival bleeding following 12 weeks twice daily brushing, compared to a negative control dentifrice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingivitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 26, 2016
Enrollment StartNov 1, 2015
Primary CompletionMar 1, 2016
Study CompletionMar 4, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.2 years ago

Interventions

Stannous Fluoridedrug

Dentifrice containing 0.454% w/w stannous fluoride

Sodium Monofluorophosphatedrug

Dentifrice containing 1000ppm fluoride as sodium monofluorophosphate